Posted AT 2:52 PM EST on 22/12/06
ProMetic shines on report of potential breakthrough
The Lancet, a prestigious British medical journal, on Friday reported results of a potential breakthrough in removing the deadly prion protein responsible for the human form of mad-cow disease from contaminated blood. It was achieved using a filter made by a ProMetic Life Sciences Inc. joint venture.
In early trading on the TSX, ProMetic stock surged higher, gaining almost 25 per cent to trade at 48 cents a share.
The full text of this article has 250 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
